Clinical trials
Prostatic Hyperplasia trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| Centro Universitario de Ciencias de la Salud, Mexico | 1 |
| GlaxoSmithKline | 1 |
| Sanofi | 1 |
| Société Internationale d'Urologie | 1 |
| Takeda | 1 |
| Zenflow, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 10 |
| Erectile Dysfunction | 2 |
| Genital Diseases, Male | 1 |
| Hyperplasia | 1 |
| Lower Urinary Tract Symptoms | 1 |
| Metabolic Syndrome | 1 |
| Prostatic Diseases | 1 |
| Signs and Symptoms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.